The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Clinical trial NCT01738035 · COMPLETED

Trial details

NCT number: NCT01738035
Sponsor: Calliditas Therapeutics AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary IgA Nephropathy

Start date: 2012-12-01
Primary completion: 2015-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.